Zymeworks ZYME Gain (loss) on available-for-sale debt securities
Gain (loss) on available-for-sale debt securities at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's gain (loss) on available-for-sale debt securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's gain (loss) on available-for-sale debt securities?
- Zymeworks (ZYME) reported gain (loss) on available-for-sale debt securities of $95K in Q1 2026.
- How has Zymeworks's gain (loss) on available-for-sale debt securities changed year-over-year?
- Zymeworks's gain (loss) on available-for-sale debt securities decreased by 62.5% year-over-year, from $253K to $95K.
- What does gain (loss) on available-for-sale debt securities mean?
- Represents the net unrealized gain or loss on the company's portfolio of available-for-sale debt securities, excluding any realized gains or losses. This metric serves as a measure of the market-driven volatility affecting the company's investment assets. It is a key component of other comprehensive income and reflects the broader economic environment's impact on corporate liquidity.